VAN ECK ASSOCIATES CORP - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 36 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$28,000
-44.0%
45,852
-11.2%
0.00%
Q1 2019$50,000
+25.0%
51,644
+2.4%
0.00%
Q4 2018$40,000
-14.9%
50,443
+38.7%
0.00%
Q3 2018$47,000
+11.9%
36,356
+6.1%
0.00%
Q2 2018$42,000
+23.5%
34,275
+36.3%
0.00%
Q1 2018$34,000
+6.2%
25,152
+7.1%
0.00%
Q4 2017$32,000
-31.9%
23,474
-24.4%
0.00%
Q3 2017$47,000
+23.7%
31,038
+4.7%
0.00%
Q2 2017$38,000
-25.5%
29,653
-28.2%
0.00%
Q1 2017$51,000
-13.6%
41,3220.0%0.00%
Q4 2016$59,000
-41.6%
41,322
-34.9%
0.00%
Q3 2016$101,000
+20.2%
63,427
+0.4%
0.00%
Q2 2016$84,000
-39.1%
63,194
-26.2%
0.00%
-100.0%
Q1 2016$138,000
+43.8%
85,603
+0.6%
0.00%0.0%
Q4 2015$96,000
+1.1%
85,110
+62.6%
0.00%0.0%
Q3 2015$95,000
-17.4%
52,328
+14.6%
0.00%0.0%
Q2 2015$115,000
+6.5%
45,643
+18.1%
0.00%0.0%
Q1 2015$108,000
+3.8%
38,648
-6.7%
0.00%0.0%
Q4 2014$104,000
-14.8%
41,413
-2.8%
0.00%0.0%
Q3 2014$122,000
+0.8%
42,607
+10.2%
0.00%0.0%
Q2 2014$121,000
+22.2%
38,648
+44.6%
0.00%
Q1 2014$99,000
+32.0%
26,723
+26.2%
0.00%
Q4 2013$75,000
-8.5%
21,179
-12.4%
0.00%
Q3 2013$82,000
+134.3%
24,181
+113.2%
0.00%
Q2 2013$35,00011,3440.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 85,378$301,0000.33%
Tower Research Capital LLC (TRC) 54,690$193,0000.03%
Psagot Value Holdings Ltd. 54,348$191,0000.01%
OPPENHEIMER & CO INC 36,450$128,0000.00%
MEEDER ASSET MANAGEMENT INC 2,900$10,0000.00%
TWO SIGMA INVESTMENTS, LP 34,571$121,0000.00%
Commonwealth Equity Services, Inc 11,100$39,0000.00%
GROUP ONE TRADING, L.P. 18,844$66,0000.00%
CITIGROUP INC 737$3,0000.00%
VAN ECK ASSOCIATES CORP 21,179$75,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders